Valuation : Olympus Corporation

Market Cap 2,050B 13.35B 11.48B 10.81B 9.85B 18.43B 1,270B 18.51B 128B 49.53B 647B 50.11B 49.03B P/E 2027 *
19.7x
P/E 2028 * 17x
Enterprise Value 2,131B 13.88B 11.94B 11.24B 10.25B 19.17B 1,321B 19.25B 133B 51.51B 673B 52.11B 50.98B EV / Sales 2027 *
1.97x
EV / Sales 2028 * 1.89x
Free-Float
94.58%
Yield 2027 *
1.59%
Yield 2028 * 1.67%
1 day-0.26%
1 week-7.77%
Current month-8.64%
1 month+0.92%
3 months+7.70%
6 months+40.92%
Current year-3.07%
1 week 1,892
Extreme 1892
2,078
1 month 1,892
Extreme 1892
2,210.5
Current year 1,302.5
Extreme 1302.5
2,210.5
1 year 1,302.5
Extreme 1302.5
2,210.5
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 01/06/2025
Director of Finance/CFO 59 01/04/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 01/04/2023
Director/Board Member 41 01/06/2019
Director/Board Member 63 01/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.26%-7.77%+5.02%-1.59% 13.35B
-0.71%-2.73%+26.23%+16.81% 224B
-1.39%-4.44%+4.71%-19.39% 144B
+2.21%-3.05%-20.32%+18.59% 125B
-1.87%-6.57%-58.32%-19.60% 65.16B
-0.84%-1.16%-20.55%-15.25% 50.05B
+0.38%-3.71%+10.44%+15.47% 49.67B
-1.23%-4.77%+15.07%+26.28% 40.81B
-1.08%-3.05%+36.83%+52.27% 39.77B
-0.88%-8.24%+113.01%+31.44% 30.96B
Average -0.58%-2.97%+11.21%+10.50% 78.25B
Weighted average by Cap. -0.46%-2.38%+6.84%+7.83%

Financials

2027 *2028 *
Net sales 1,080B 7.03B 6.05B 5.7B 5.19B 9.72B 669B 9.76B 67.55B 26.11B 341B 26.42B 25.84B 1,118B 7.28B 6.26B 5.9B 5.37B 10.05B 693B 10.09B 69.89B 27.01B 353B 27.33B 26.74B
Net income 105B 683M 588M 554M 505M 944M 65.03B 948M 6.56B 2.54B 33.13B 2.57B 2.51B 122B 792M 682M 642M 585M 1.09B 75.4B 1.1B 7.61B 2.94B 38.41B 2.98B 2.91B
Net Debt 81.71B 532M 458M 431M 393M 735M 50.63B 738M 5.11B 1.97B 25.79B 2B 1.95B 64.09B 417M 359M 338M 308M 576M 39.71B 579M 4.01B 1.55B 20.23B 1.57B 1.53B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
10/09/26 ¥1,923.50 -0.26% 3,920,100
09/09/26 ¥1,928.50 -1.86% 5,583,200
08/09/26 ¥1,965.00 -2.58% 2,976,200
07/09/26 ¥2,017.00 -2.13% 3,943,400
04/09/26 ¥2,061.00 -0.34% 4,332,400
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,928.50JPY
Average target price
2,161.54JPY
Spread / Average Target
+12.08%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!